The Bouvier Bernois has serious, well-documented health challenges that represent the most significant concern for anyone considering the breed. The average lifespan of 7 to 10 years is short for a large breed, and the primary driver of this shortened lifespan is cancer. In the 2005 BMDCA health study, 67 percent of all Bernese Mountain Dogs that died succumbed to some form of cancer. That statistic is not an outlier or an artifact of a biased sample - it reflects a genuine and persistent breed-wide vulnerability that the parent club, breeders, and researchers have been working to address for decades.
Histiocytic sarcoma stands as the breed's defining health challenge. This aggressive cancer of the histiocytes - immune cells present in lymph nodes and multiple organ systems - affects approximately 25 percent of all Bernese Mountain Dogs. It occurs in several forms: localized histiocytic sarcoma, which most commonly affects bones, joints, skin, and lungs; disseminated histiocytic sarcoma, which involves multiple organs simultaneously; and hemophagocytic histiocytic sarcoma, which originates in the spleen and progresses rapidly. The mean age of onset is approximately 6.5 years, males and females are equally affected, and the median survival time after diagnosis is measured in weeks rather than months. Antagene has developed a genetic risk assessment test that evaluates predisposition, and the BMDCA maintains the HSIMS database to track cases and support ongoing research.
Beyond cancer, the breed faces the orthopedic concerns common to large, heavy dogs. Hip dysplasia and elbow dysplasia are both significant in the breed and are required CHIC screening tests. Degenerative myelopathy, a progressive spinal cord disease that leads to hind limb weakness and eventual paralysis, is tested via DNA analysis for SOD1 mutations. Von Willebrand disease, an inherited bleeding disorder, is present in the breed and testable through DNA analysis. Gastric dilatation-volvulus, or bloat, is a life-threatening emergency that affects deep-chested large breeds, and the Bernese is no exception.
Eye conditions including various forms of cataracts are documented in the breed, and annual ACVO ophthalmologist examinations are a required component of CHIC testing. Owners are encouraged to maintain regular eye health monitoring throughout the dog's life. The comprehensive nature of the BMDCA's recommended health testing protocol reflects the breadth of health concerns in the breed, and prospective buyers should verify that both parents have current OFA results and a CHIC number. Reviewing both parents in the BernerGarde database provides insight into health patterns across multiple generations that individual test results alone cannot capture.
The emotional cost of the breed's health vulnerabilities is something that cannot be assessed through statistics alone. Berner owners invest deeply in dogs that frequently die young, and the grief associated with losing a beloved companion at six or seven years of age is a reality of the breed that must be acknowledged honestly. The breed's devoted following persists despite these challenges because the quality of the relationship a Berner offers is, for many people, worth the heartbreak. But anyone considering the breed should enter the commitment with clear eyes about what may lie ahead.
Common Health Issues
- Histiocytic sarcoma - An aggressive cancer of the histiocytes - immune cells found in lymph nodes and multiple organs - that is the single most significant health concern in the breed. Approximately 25 percent of Bernese Mountain Dogs are affected, and the disease has been shown to have a heritable genetic component. It occurs in localized, disseminated, and hemophagocytic forms, all of which carry a grave prognosis. Antagene offers a risk assessment test that evaluates genetic predisposition.
- Hip dysplasia - Abnormal development of the hip joint leading to progressive cartilage deterioration, chronic pain, and reduced mobility. The condition is common in large breeds and is a required CHIC screening test for Bernese Mountain Dogs. OFA radiographic evaluation of both parents before breeding is the standard preventive measure.
- Elbow dysplasia - A group of developmental abnormalities affecting the elbow joint that can cause lameness and chronic pain. Elbow evaluation is a required component of the BMDCA CHIC testing protocol, reflecting the significant incidence of the condition in the breed.
- Degenerative myelopathy - A progressive neurological disease affecting the spinal cord that leads to weakness and eventual paralysis of the hind limbs. DNA testing for the SOD1 mutation is a required CHIC test for Bernese Mountain Dogs, and results should be factored into breeding decisions.
- Gastric dilatation-volvulus (bloat) - A life-threatening emergency in which the stomach fills with gas and may rotate on its axis, cutting off blood supply. Deep-chested large breeds like the Bernese Mountain Dog are at elevated risk. Prophylactic gastropexy during spay or neuter surgery is increasingly recommended.
- Von Willebrand disease - An inherited bleeding disorder caused by deficiency of a clotting factor protein. DNA testing is available and is an elective component of the BMDCA health testing protocol. Both parents should be tested before breeding to avoid producing affected offspring.
- Progressive retinal atrophy and cataracts - Various eye conditions including cataracts of different types are documented in Bernese Mountain Dogs. Annual ACVO ophthalmologist examinations are a required CHIC test for the breed, and owners are encouraged to maintain eye health monitoring throughout the dog's life.
Preventive Care & Health Monitoring
- Complete BMDCA CHIC testing protocol for breeding dogs - Required tests include OFA hip evaluation, OFA elbow evaluation, ACVO eye examination, cardiac evaluation, and DNA testing for degenerative myelopathy (both SOD1 mutations). At least one elective test from von Willebrand disease DNA, thyroid panel, or histiocytic sarcoma risk assessment must also be completed.
- Antagene histiocytic sarcoma risk test - A genetic risk assessment tool that evaluates a dog's predisposition to histiocytic sarcoma. Results should be entered into the HSIMS database maintained by the BMDCA to contribute to ongoing research and inform breeding decisions aimed at reducing the incidence of this devastating cancer.
- BernerGarde database review before purchasing a puppy - Prospective buyers should look up both parents in the BernerGarde database, which tracks health, longevity, and cause of death across multiple generations. This open-access resource provides far more meaningful health information than individual test results alone.
- Bloat prevention feeding protocol - Feed two or three smaller meals daily rather than one large meal, use a slow-feeder bowl for dogs that eat rapidly, and avoid strenuous exercise for at least one hour after eating. Discuss prophylactic gastropexy with your veterinarian, particularly if the dog will be spayed or neutered.
- Heat management during warm weather - The heavy double coat and large body mass make the Bernese Mountain Dog susceptible to heat stress. Provide access to shade and cool water at all times, avoid exercise during the hottest parts of the day, and watch for signs of heat exhaustion including excessive panting, drooling, and lethargy.
- Regular veterinary cancer screening after age five - Given the breed's high cancer incidence, discuss an enhanced screening schedule with your veterinarian that may include periodic abdominal ultrasound, chest radiographs, and blood work to detect early signs of malignancy. Early detection does not guarantee successful treatment but may provide additional options.